Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 340

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 340
---
 Inc. and Liminatus Pharma, LLC to perform certain services for the Company and Liminatus Pharma, LLC. At the time of the agreement signing $ 125,000was owed to Benjamin Securities, Inc. as a deposit, with an additional $ 485,000owed at consummation of the business combination. The Company and Benjamin Securities, Inc. subsequently amended the agreement shortly after execution to delay the services provided until the business combination becomes effective. As such, noobligations are owed to Benjamin Securities, Inc. until the business combination becomes effective.

NOTE 8. STOCKHOLDERS’ DEFICIT Preferred stock—The Company is authorized to issue 1,000,000shares of preferred stock with a par value of $ 0.0001and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2024 and December 31, 2023, there were noshares of preferred stock issued or outstanding. Class A common stock—The Company is authorized to issue 280,000,000shares of Class A common stock with a par value of $ 0.0001per share. As of December 31, 2024 and December 31, 2023, there were 7,074,477and 7,306,609, respectively, shares issuedand outstanding, of which 174,477 and 406,609 aresubject to possible redemption, respectively. Class B common stock—The Company is authorized to issue 20,000,000Class B common stock with a par value of $ 0.0001per share. At both December 31, 2024 and December 31, 2023, there were noshares of Class B common stock outstanding. Stockholders of record are entitled to onevote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the

<div align='center'>F-96</div>

Company’s stockholders except as required by law. Unless specified in the Company’s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law or applicable stock exchange rules, the affirmative vote of a majority of the Company’s shares of common stock that are voted is required to approve any such matter voted on